TCG Crossover Management, LLC
- SEC CIK
- 0001839948
- Latest filing
- Aug 14, 2026
VTGN holding history
Vistagen Therapeutics, Inc. in every 13F filed by TCG Crossover Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VTGN overviewAll 13F holders of VTGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −2,676,580−100.0% | Sold out | Holders |
| Q1 2026 | 2,676,580 | $1.53M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 2,676,580 | $1.77M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2,676,580 | $9.50M | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2025 | 2,676,580 | $5.35M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2025 | 2,676,580 | $6.69M | 0.9% | 00.0% | Unchanged | Holders |
| Q4 2024 | 2,676,580 | $7.90M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2024 | 2,676,580 | $8.06M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 2,676,580 | $9.31M | 1.0% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,676,580 | $14.1M | 1.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,676,580 | $13.8M | 1.5% | +2,676,580 | New | Holders |